Matthew C. Email and Phone Number
Matthew C. work email
- Valid
- Valid
- Valid
Matthew C. personal email
Translational and Molecular Scientist with a decade of experience in cell therapy drug development in oncology. I have worked from the discovery stage to early phase clinical trials for CAR-T, TCR-T and Allo-NK therapeutics.I am presently the Director of Preclinical and Translational Research at Indapta therapeutics where we are developing allogenic g-NK cells as an off the shelf therapy in oncology and autoimmune diseases.
-
Director, Preclinical And Translational ResearchIndapta Therapeutics Jan 2024 - PresentSeattle & Houston , UsIndapta Therapeutics is a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer. -
Director, Translational SciencesAlaunos Therapeutics Oct 2021 - Sep 2023Houston, Texas, UsCurrently leading a Team of talented scientists and associates to execute and deliver on target-discovery, translation into the clinic, and biomarker support of planned and ongoing clinical studies for Neoantigen-target TCR-T cell therapies in solid tumors. -
Associate Director, Cell Therapy Biomarker DiscoveryZiopharm Oncology May 2020 - Oct 2021Led a small team of scientists and lab technicians, to developed and operationalized the clinical immune monitoring and biomarker strategies to support an early phase investigation study of neoantigen-specific TCR-T therapy in advanced solid tumors.
-
Senior ScientistBellicum Pharmaceuticals, Inc. Mar 2019 - May 2020Houston, Texas, UsTranslational research scientist for early clinical stage CAR-T program in advanced solid tumors. Scope of responsibilities include biomarker strategy, CRO-management, and cross-functional coordination of translational research activities for the program. -
Scientist IiBellicum Pharmaceuticals, Inc. Oct 2016 - Mar 2019Houston, Texas, UsResearch & development scientist for next generation CAR-T platforms and other adoptive cell therapy strategies for application in solid and hematopoietic malignancies. Led independent research projects and collaborated in cross-functional teams. This work encompassed development stages all the way from technology conception to supporting various translational aspects of late-phase cell therapy and small molecule programs. -
Research InternBellicum Pharmaceuticals, Inc. Jun 2013 - Oct 2016Houston, Texas, UsResearch intern working on novel molecular switches for enhancing the safety and efficacy of adoptive cell therapies. -
Phd CandidateBaylor College Of Medicine Aug 2009 - Oct 2016Houston, Texas, UsUnder the mentorship of David M. Spencer, PhD, and Kevin M. Slawin, MD I received my PhD in Translational Biology and Molecular Medicine. My thesis work is focus on cancer vaccine development. More specifically my work focused on making cancer vaccines more efficacious through the use of proprietary technologies as well as more accessible by packaging these types of therapies in to a more universal "off-the-shelf" treatment. This work was published as, "MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity." -
Co-FounderEnventure.Org, Llc May 2012 - Apr 2015Houston, Texas, Usenventure is a non-profit organization that aims to build a home for Houston’s medical entrepreneurs by leveraging the vast resources of the Texas Medical Center through stimulating lectures, hands-on workshops, one-on-one mentor- ship, diverse educational programs, and accessible resources and grant funding of early stage medical startups in Houston. -
Utmd Summer Undergraduate Research Program InternMd Anderson Cancer Center May 2008 - Aug 2008Houston, Tx, UsDetermination and mutational analysis of Rotavirus NSP4 viroporin activity. Publication: Hyser, J.M., Collinson-pautz, M.R. & Utama, Budi Estes, M.K. Rotavirus Disrupts Calcium Homeostasis by NSP4 Viroporin Activity. mBio 1, (2010). -
Merck Undergraduate Summer Research InternAugustana College May 2007 - Aug 2007Rock Island, Il, UsAs a summer research intern I examined the subcellular localization of the glutamate dehydrogenase isozymes in S. ceravisiae (yeast).
Matthew C. Skills
Matthew C. Education Details
-
Baylor College Of MedicineTranslational Biology And Molecular Medicine -
Augustana CollegeBiochemistry
Frequently Asked Questions about Matthew C.
What company does Matthew C. work for?
Matthew C. works for Indapta Therapeutics
What is Matthew C.'s role at the current company?
Matthew C.'s current role is Translational Scientist, Immune-oncology, Effective Team Leader.
What is Matthew C.'s email address?
Matthew C.'s email address is mc****@****cum.com
What schools did Matthew C. attend?
Matthew C. attended Baylor College Of Medicine, Augustana College.
What are some of Matthew C.'s interests?
Matthew C. has interest in Motorsports, Cooking, Entrepreneurship, Biotechnology, Mechanics.
What skills is Matthew C. known for?
Matthew C. has skills like Biotechnology, Western Blotting, Molecular Biology, Molecular Cloning, Flow Cytometry, Immunofluorescence, Immunology, Tissue Culture, Vaccines, Animal Models, Tumor Immunology, Immunological Assays.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial